| Literature DB >> 30100082 |
Azadeh Elmi1, Elizabeth S McDonald1, David Mankoff2.
Abstract
Uncontrolled growth is a hallmark of cancer; imaging cell proliferation can provides an early indicator of therapeutic response. This capability is especially well-matched to the emerging cell cycle-specific chemotherapeutics with the goal of identifying patients that benefit from these treatments early in the course of treatment to guide personalized therapy. This article focuses on investigational cell proliferation imaging PET radiotracers to evaluate tumor proliferation in the setting of cell cycle-targeted chemotherapy and endocrine therapy for metastatic breast cancer.Entities:
Keywords: Breast cancer; PET imaging; Radiotracer; Targeted therapies; Tumor proliferation
Mesh:
Substances:
Year: 2018 PMID: 30100082 PMCID: PMC6092945 DOI: 10.1016/j.cpet.2018.02.007
Source DB: PubMed Journal: PET Clin ISSN: 1556-8598